Polares is revolutionizing the mitral regurgitation (MR) market with an innovative endoluminal implanted augmentation device. Unlike current endoluminal transcatheter mitral valve therapies that mechanically clip leaflets together, which restricts future interventions to total valve replacement, Polares' approach potentially treats and preserves options for future mitral valve therapies across the diverse MR patient population